Literature DB >> 20890316

Diagnosis and management of IBS.

Sarah Khan1, Lin Chang.   

Abstract

IBS is a common gastrointestinal condition characterized by chronic or recurrent abdominal pain associated with altered bowel habits. IBS is considered a functional bowel disorder (that is, not defined by structural or biochemical abnormalities) and is diagnosed using symptom-based criteria. Limited and judicious use of diagnostic testing is recommended, particularly in patients with typical symptoms of IBS without alarm signs and symptoms. Management of IBS is based on a multifactorial approach and includes establishment of an effective patient-provider relationship, education, reassurance, dietary alterations, pharmacotherapy, behavioral and psychological treatment. Patient-centered care is recommended, in which management is focused on the patient's most bothersome and impactful symptoms, their preferences and previous experiences with treatment, and addressing factors associated with the onset and exacerbation of symptoms. Pharmacotherapy is typically targeted against the predominant symptom. This Review discusses the current evidence-based recommendations for the diagnosis and management of IBS. An improved understanding of the recommended diagnostic and therapeutic approaches for IBS will lead to greater patient satisfaction, as well as reduced health-care costs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20890316     DOI: 10.1038/nrgastro.2010.137

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  133 in total

1.  The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial.

Authors:  William D Chey; Borko Nojkov; Joel H Rubenstein; Richard R Dobhan; Joel K Greenson; Brooks D Cash
Journal:  Am J Gastroenterol       Date:  2010-02-23       Impact factor: 10.864

Review 2.  The irritable bowel syndrome: review and a graduated multicomponent treatment approach.

Authors:  D A Drossman; W G Thompson
Journal:  Ann Intern Med       Date:  1992-06-15       Impact factor: 25.391

Review 3.  Herbal medicines for treatment of irritable bowel syndrome.

Authors:  J P Liu; M Yang; Y X Liu; M L Wei; S Grimsgaard
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

4.  Quality of life in persons with irritable bowel syndrome: development and validation of a new measure.

Authors:  D L Patrick; D A Drossman; I O Frederick; J DiCesare; K L Puder
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

5.  Is irritable bowel syndrome a diagnosis of exclusion?: a survey of primary care providers, gastroenterologists, and IBS experts.

Authors:  Brennan M R Spiegel; Mary Farid; Eric Esrailian; Jennifer Talley; Lin Chang
Journal:  Am J Gastroenterol       Date:  2010-03-02       Impact factor: 10.864

Review 6.  New treatments for irritable bowel syndrome in women.

Authors:  Mopelola A Adeyemo; Lin Chang
Journal:  Womens Health (Lond)       Date:  2008-11

7.  Comparison of digestibility and breath hydrogen gas excretion of fructo-oligosaccharide, galactosyl-sucrose, and isomalto-oligosaccharide in healthy human subjects.

Authors:  T Oku; S Nakamura
Journal:  Eur J Clin Nutr       Date:  2003-09       Impact factor: 4.016

8.  Increased prevalence of irritable bowel syndrome in patients with bronchial asthma.

Authors:  A Roussos; P Koursarakos; D Patsopoulos; I Gerogianni; N Philippou
Journal:  Respir Med       Date:  2003-01       Impact factor: 3.415

Review 9.  Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis.

Authors:  A C Ford; N J Talley; P S Schoenfeld; E M M Quigley; P Moayyedi
Journal:  Gut       Date:  2008-11-10       Impact factor: 23.059

10.  Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial.

Authors:  C J Bijkerk; N J de Wit; J W M Muris; P J Whorwell; J A Knottnerus; A W Hoes
Journal:  BMJ       Date:  2009-08-27
View more
  31 in total

Review 1.  Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature.

Authors:  Nathaniel Aviv Cohen; Nitsan Maharshak
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

Review 2.  Irritable bowel syndrome.

Authors:  Paul Enck; Qasim Aziz; Giovanni Barbara; Adam D Farmer; Shin Fukudo; Emeran A Mayer; Beate Niesler; Eamonn M M Quigley; Mirjana Rajilić-Stojanović; Michael Schemann; Juliane Schwille-Kiuntke; Magnus Simren; Stephan Zipfel; Robin C Spiller
Journal:  Nat Rev Dis Primers       Date:  2016-03-24       Impact factor: 52.329

3.  Autonomic response to a visceral stressor is dysregulated in irritable bowel syndrome and correlates with duration of disease.

Authors:  P Cheng; W Shih; M Alberto; A P Presson; A Licudine; E A Mayer; B D Naliboff; L Chang
Journal:  Neurogastroenterol Motil       Date:  2013-07-03       Impact factor: 3.598

Review 4.  The role of eosinophils and mast cells in intestinal functional disease.

Authors:  Marjorie M Walker; Alasdair Warwick; Chuin Ung; Nicholas J Talley
Journal:  Curr Gastroenterol Rep       Date:  2011-08

Review 5.  Corticotrophin-releasing factor 1 activation in the central amygdale and visceral hyperalgesia.

Authors:  Y Taché
Journal:  Neurogastroenterol Motil       Date:  2015-01       Impact factor: 3.598

6.  Prevalence of organic colonic lesions in patients meeting Rome III criteria for diagnosis of IBS: a prospective multi-center study utilizing colonoscopy.

Authors:  Shunji Ishihara; Kazuo Yashima; Yoshinori Kushiyama; Akio Izumi; Kousaku Kawashima; Hirofumi Fujishiro; Haruhiko Kojo; Yoshinori Komazawa; Tetsuro Hamamoto; Tetsuo Yamamoto; Yuichiro Sasaki; Tatsunori Shimizu; Eiji Okamoto; Teiji Yoshimura; Koichiro Furuta; Naoya Noguchi; Hisao Tanaka; Yoshikazu Murawaki; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2012-03-30       Impact factor: 7.527

7.  Evidence-based clinical practice guidelines for irritable bowel syndrome.

Authors:  Shin Fukudo; Hiroshi Kaneko; Hirotada Akiho; Masahiko Inamori; Yuka Endo; Toshikatsu Okumura; Motoyori Kanazawa; Takeshi Kamiya; Ken Sato; Toshimi Chiba; Kenji Furuta; Shigeru Yamato; Tetsuo Arakawa; Yoshihide Fujiyama; Takeshi Azuma; Kazuma Fujimoto; Tetsuya Mine; Soichiro Miura; Yoshikazu Kinoshita; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2014-12-12       Impact factor: 7.527

8.  Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.

Authors:  Rebeca Martín; Florian Chain; Sylvie Miquel; Jane M Natividad; Harry Sokol; Elena F Verdu; Philippe Langella; Luis G Bermúdez-Humarán
Journal:  Hum Vaccin Immunother       Date:  2014-04-14       Impact factor: 3.452

9.  Microscopic colitis - a missed diagnosis in diarrhea-predominant irritable bowel syndrome.

Authors:  Adriana Stoicescu; Gabriel Becheanu; Mona Dumbrava; Cristian Gheorghe; Mircea Diculescu
Journal:  Maedica (Buchar)       Date:  2012-01

Review 10.  Cognitive-behavioral therapy for the management of irritable bowel syndrome.

Authors:  Qing-Lin Tang; Guo-Yao Lin; Ming-Qing Zhang
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.